News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orion Pharma's Mixed Results; Abbott Laboratories (ABT) Shares Drop After Study Of Simdax Disappoints


11/15/2005 12:02:19 PM

Nov. 15 (Bloomberg) -- Shares of Orion Oyj, the Nordic region's third-largest drugmaker, dropped as much as 14 percent after researchers said the Simdax heart failure treatment caused some complications and didn't lower death rates.

Read at Bloomberg
Read at BusinessWeek
Read at Chicago Sun Times

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES